• 1. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere
• 2. An analyte-triggered artificial peroxidase system based on dimanganese complex for a versatile enzyme assay?
  Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453
• 3. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 4. Aggregation of biologically important peptides and proteins: inhibition or acceleration depending on protein and metal ion concentrations
  Benjamin Gabriel Poulson,Kacper Szczepski,Joanna Izabela Lachowicz,Lukasz Jaremko,Abdul-Hamid Emwas,Mariusz Jaremko RSC Adv., 2020,10, 215-227
• 5. Aggregation-induced emission leading to two distinct emissive species in the solid-state structure of high-dipole organic chromophores?
  Felix Witte,Philipp Rietsch,Nithiya Nirmalananthan-Budau,Florian Weigert,Jan P. G?tze,Ute Resch-Genger,Siegfried Eigler,Beate Paulus Phys. Chem. Chem. Phys., 2021,23, 17521-17529

• Solvents and Organic Chemicals Organic Compounds Benzenoids Naphthalenes Naphthalenecarboxamides
• Solvents and Organic Chemicals Organic Compounds Benzenoids Naphthalenes Naphthalenecarboxylic acids and derivatives Naphthalenecarboxamides

Comprehensive Overview of N-4-chloro-3-(1,1-dioxo-1lambda6,2-thiazolidin-2-yl)phenylnaphthalene-1-carboxamide (CAS No. 941899-68-9)

N-4-chloro-3-(1,1-dioxo-1lambda6,2-thiazolidin-2-yl)phenylnaphthalene-1-carboxamide, with the CAS number 941899-68-9, is a specialized organic compound that has garnered significant attention in pharmaceutical and biochemical research. This compound belongs to the class of naphthalene carboxamide derivatives, which are known for their diverse biological activities. The presence of a thiazolidine dione moiety and a chlorophenyl group in its structure makes it a promising candidate for drug discovery, particularly in targeting metabolic and inflammatory pathways.

In recent years, the demand for novel small-molecule inhibitors and therapeutic agents has surged, driven by advancements in precision medicine and personalized therapies. Researchers are particularly interested in compounds like N-4-chloro-3-(1,1-dioxo-1lambda6,2-thiazolidin-2-yl)phenylnaphthalene-1-carboxamide due to their potential applications in modulating enzyme activity and receptor binding. Its unique structural features, including the sulfonyl group and aromatic rings, contribute to its stability and bioavailability, making it a valuable scaffold for further chemical modifications.

The synthesis of CAS 941899-68-9 involves multi-step organic reactions, often starting with the coupling of naphthalene-1-carboxylic acid with appropriately substituted aniline derivatives. The incorporation of the 1,1-dioxo-1lambda6,2-thiazolidine ring is a critical step, requiring careful optimization to achieve high yields and purity. Analytical techniques such as HPLC, NMR spectroscopy, and mass spectrometry are routinely employed to characterize this compound, ensuring its suitability for preclinical studies.

One of the most searched questions related to this compound is its potential role in drug development and disease treatment. Preliminary studies suggest that N-4-chloro-3-(1,1-dioxo-1lambda6,2-thiazolidin-2-yl)phenylnaphthalene-1-carboxamide may exhibit anti-inflammatory and antioxidant properties, aligning with current trends in targeting chronic diseases such as diabetes and neurodegenerative disorders. Additionally, its molecular weight and logP value indicate favorable pharmacokinetic properties, which are crucial for oral bioavailability.

From an industrial perspective, the scalability of CAS 941899-68-9 production is a topic of interest. Manufacturers are exploring greener synthetic routes, such as catalytic methods and solvent-free reactions, to reduce environmental impact. The compound's patent status and regulatory compliance are also frequently discussed, as they influence its commercial viability and adoption in clinical trials.

In summary, N-4-chloro-3-(1,1-dioxo-1lambda6,2-thiazolidin-2-yl)phenylnaphthalene-1-carboxamide represents a fascinating area of research with broad implications for medicinal chemistry and pharmacology. Its structural complexity and functional versatility make it a compelling subject for both academic and industrial investigations. As the scientific community continues to explore its potential, this compound may pave the way for innovative therapies addressing unmet medical needs.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)